Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

RNA Therapeutics Company Raises $30M in First Venture Round

Kevin Weeks

A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round

Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M

Heartbeat graphic

A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own. . . . → Read More: Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M

Synthetic DNA Company Raising $70 Million in IPO

NASDAQ share price display

A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO

Gene Silencing Technology Licensed in $3.7B Deal

RNA strand illustration

Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co . . . → Read More: Gene Silencing Technology Licensed in $3.7B Deal

Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

T-cells illustration

A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

Biotech in $3.7B Licensing Deal for Hepatitis-B

Hepatitis-B virus

A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B

$29.5M Funding Raised for Sinus Drug Delivery Company

Sinus doctor

A company developing a drug delivery technology to treat chronic sinus conditions is raising $29.5 million in its second venture financing round. . . . → Read More: $29.5M Funding Raised for Sinus Drug Delivery Company

Spin-Off Company Developing New Antibiotics

MRSA bacteria

A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics

Virtual Reality Therapy Company Gains $5.1M in Early Funds

Scene from VR program

A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds

Start-Up Offers Digital Health Prescriptions, Raises $1.8M

Texting

A new enterprise that offers electronic health service prescriptions is raising $1.8 million in seed funds and starting a program for prescribing digital health services simultaneously to groups of people. . . . → Read More: Start-Up Offers Digital Health Prescriptions, Raises $1.8M